Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study
Authors
Keywords
-
Journal
MEDICAL DECISION MAKING
Volume -, Issue -, Pages 0272989X1985989
Publisher
SAGE Publications
Online
2019-07-03
DOI
10.1177/0272989x19859899
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa
- (2018) Ola Brønstad Brynildsrud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study
- (2018) Reza Yaesoubi et al. PLOS MEDICINE
- Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data
- (2017) Caroline L Trotter et al. LANCET INFECTIOUS DISEASES
- Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
- (2017) F. Marc LaForce et al. Human Vaccines & Immunotherapeutics
- Projecting social contact matrices in 152 countries using contact surveys and demographic data
- (2017) Kiesha Prem et al. PLoS Computational Biology
- Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data
- (2016) Fati Sidikou et al. LANCET INFECTIOUS DISEASES
- Evaluation of response strategies against epidemics due toNeisseria meningitidisC in Niger
- (2016) Halima Boubacar Maïnassara et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
- (2015) Andromachi Karachaliou et al. CLINICAL INFECTIOUS DISEASES
- Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina Faso
- (2015) Anaïs Colombini et al. CLINICAL INFECTIOUS DISEASES
- From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project
- (2015) M. Teresa Aguado et al. CLINICAL INFECTIOUS DISEASES
- Technical Development of a New Meningococcal Conjugate Vaccine
- (2015) Carl E. Frasch et al. CLINICAL INFECTIOUS DISEASES
- Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso—Implications for introduction of PsA-TT into the Expanded Programme on Immunization
- (2015) Sarah A. Meyer et al. VACCINE
- Spatio-Temporal Factors Associated with Meningococcal Meningitis Annual Incidence at the Health Centre Level in Niger, 2004–2010
- (2014) Juliette Paireau et al. PLoS Neglected Tropical Diseases
- Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination
- (2013) Jean-Marc Collard et al. BMC INFECTIOUS DISEASES
- Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt
- (2013) Sara Tartof et al. PLoS One
- Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact
- (2013) Hannah Christensen et al. VACCINE
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
- (2012) Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba, Idrissa Sanou, Abdoul–Salam Ouédraogo, Rasmata Ouédraogo, Lassana Sangaré, Denis Kandolo, Flavien Aké, Inger Marie Saga, Thomas A. Clark, Lara Misegades, Stacey W. Martin, Jennifer Dolan Thomas, Sylvestre R. Tiendrebeogo, Musa Hassan-King, Mamoudou H. Djingarey, Nancy E. Messonnier, Marie-Pierre Préziosi, F. Marc LaForce, Dominique A. Caugant CLINICAL INFECTIOUS DISEASES
- Seasonality of meningitis in Africa and climate forcing: aerosols stand out
- (2012) L. Agier et al. Journal of the Royal Society Interface
- Effect of vaccines on bacterial meningitis worldwide
- (2012) Peter B McIntyre et al. LANCET
- Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
- (2012) Ryan T Novak et al. LANCET INFECTIOUS DISEASES
- Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
- (2012) Mamoudou H. Djingarey et al. VACCINE
- Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt
- (2012) Brian Greenwood VACCINE
- Development of a group A meningococcal conjugate vaccine,MenAfriVacTM
- (2012) Carl Frasch et al. Human Vaccines & Immunotherapeutics
- Modelling meningococcal meningitis in the African meningitis belt
- (2011) T. J. IRVING et al. EPIDEMIOLOGY AND INFECTION
- Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
- (2011) Samba O. Sow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
- (2011) Isabelle Delrieu et al. PLoS One
- Costs and impact of meningitis epidemics for the public health system in Burkina Faso
- (2011) Anaïs Colombini et al. VACCINE
- Meningococcal carriage by age: a systematic review and meta-analysis
- (2010) Hannah Christensen et al. LANCET INFECTIOUS DISEASES
- Costs for Households and Community Perception of Meningitis Epidemics in Burkina Faso
- (2009) Anaïs Colombini et al. CLINICAL INFECTIOUS DISEASES
- A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt
- (2009) Judith E. Mueller et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution
- (2009) F. Marc LaForce et al. VACCINE
- Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults
- (2009) Richarda M. de Voer et al. VACCINE
- INFECTIOUS DISEASE: An Ill Wind, Bringing Meningitis
- (2008) L. Roberts SCIENCE
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
- (2008) Joël Mossong et al. PLOS MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started